• ARL4C and EdU Assay Strategy for S-Phase Biology

  2026-08-28

  A translational framework for converting ARL4C-driven rheumatoid arthritis fibroblast-like synoviocyte biology into an interpretable S-phase, drug-response, and mechanistic validation workflow using the EdU Cell Proliferation Kit (TMB).

• O-GlcNAc–HUWE1–TfR1 Signaling in Preeclampsia

  2026-08-28

  This study identifies an O-GlcNAc–HUWE1–TfR1 regulatory axis that links trophoblast ferroptosis, iron uptake, and defective syncytialization in preeclampsia. Its combination of placental observations, O-GlcNAc modification proteomics, mechanistic validation, and mouse experiments provides a framework for testing how post-translational regulation of iron handling contributes to adverse pregnancy outcomes.

• Lipid Peroxidation Assay: From MDA to Ferroptosis

  2026-08-27

  The Lipid Peroxidation (MDA) Assay Kit enables sensitive MDA quantification while helping researchers distinguish oxidative damage from ferroptosis-specific mechanisms. This guide uses doxorubicin-induced liver injury research to build a more rigorous framework for assay selection, interpretation, and validation.

• Sulfo-Cy3 NHS Ester for Vascular Protein Labeling

  2026-08-27

  Learn how to use Sulfo-Cy3 NHS Ester as a water-compatible label for proteins, peptides, endothelial uptake assays, and quantum-dot conjugates. The workflow emphasizes controlled amine coupling, clean separation, quantitative fluorescence, and controls suited to the AIBP–LRP2–HDL–miR-223 vascular remodeling axis.

• JC-1 for Mitochondrial Membrane Potential Assays

  2026-08-26

  JC-1 is a cationic fluorescent probe for mitochondrial membrane potential that changes from green monomer fluorescence to red aggregate fluorescence as membrane potential increases. The 5,6-dichloro-2-[(E)-3-(5,6-dichloro-1,3-diethylbenzimidazol-3-ium-2-yl)prop-2-enylidene]-1,3-diethylbenzimidazole iodide signal supports mitochondrial dysfunction research and apoptosis detection, but it should be interpreted with viability and mechanistic controls.

• Sulfo-Cy3 NHS Ester for Vascular Protein Labeling

  2026-08-26

  Sulfo-Cy3 NHS Ester combines water compatibility with efficient primary-amine labeling, making it useful for soluble protein conjugation, uptake assays, and vascular cell studies. Its sulfonated structure is particularly valuable when conventional Cy3 workflows cause precipitation, denaturation, or dye-dye quenching.

• Instant Clot-Forming TXA–NO–Propolis Dressings

  2026-08-25

  The reference study presents a bi-layer wound dressing that combines tranexamic acid, an NO donor, and propolis to address hemorrhage and bacterial contamination in traumatic wounds. Its assay and microscopy results support rapid fibrin stabilization alongside strong activity against Staphylococcus aureus and multidrug-resistant Acinetobacter baumannii, while also indicating the need for further in vivo validation.

• Tubastatin A: From HDAC6 Biology to Translation

  2026-08-25

  Tubastatin A is a selective HDAC6 inhibitor that connects α-tubulin acetylation and nonhistone protein regulation with cancer biology, inflammation, neuroprotection, and ischemia-reperfusion injury. This thought-leadership guide interprets porcine cardiac-arrest evidence, defines practical assay parameters, and outlines a translational strategy without overstating preclinical findings.

• Sulfo-Cy3 NHS Ester for Vascular Assays

  2026-08-24

  Sulfo-Cy3 NHS Ester combines aqueous compatibility with amine-reactive labeling for tracking proteins, HDL-associated cargo, and endothelial uptake. This workflow translates the AIBP–LRP2–HDL–miR-223 findings into practical fluorescence assays while preserving options for low-solubility proteins and QD-dye conjugates.

• Grazoprevir hydrate: HCV Assay Workflows

  2026-08-24

  Build genotype-aware HCV replication assays around the potent NS3/4A inhibitor Grazoprevir hydrate, from DMSO stock preparation to orthogonal validation. Practical workflow parameters, control strategies, and troubleshooting guidance help connect picomolar biochemical activity with interpretable cellular and translational results.

• Protease Inhibitor Cocktail EDTA-Free Guide

  2026-08-23

  Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) helps limit endogenous proteolysis during cell lysis and protein sample preparation. It is suited to phosphorylation-sensitive and divalent-cation-dependent workflows, but inhibitor compatibility should be validated for catalytic assays, imaging samples, and proteases outside the cocktail’s stated coverage.

• Cy7 NHS Ester: Practical Labeling Guide

  2026-08-22

  Sulfo-Cy7 NHS Ester is a water-soluble near-infrared dye for bioimaging and amino-group labeling of proteins and peptides when organic co-solvents may compromise sample stability. This guide covers reagent handling, conjugation setup, QC, and limitations; it is not intended for long-term storage of prepared dye solutions or poorly controlled light-exposure workflows.

• S Tag Peptide: Fusion Tag Workflow Guide

  2026-08-21

  S Tag Peptide (SKU A6007) supports recombinant protein detection, antibody-based capture, and protein solubility improvement when its sequence is genetically fused to a target. This guide covers construct planning, peptide handling, QC, and limitations; it is not suitable for ethanol-based systems or long-term storage of aqueous solutions.

• How O-GlcNAcylation Rewires Wnt-Driven Bone Formation

  2026-08-20

  The reference study identifies O-GlcNAcylation as a mechanistic link between Wnt3a signaling, PDK1 stabilization, aerobic glycolysis, and osteoblast-mediated bone formation. Its experimental design shows how temporal signaling analysis, lineage-specific genetic perturbation, metabolic measurements, and fracture-healing models can distinguish a causal metabolic pathway from a downstream correlation.

• Polyclonal Goat Anti-Human IgG Antibody: Assay Design

  2026-08-20

  Discover how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody supports variant-aware serology, imaging, Western blotting, and flow cytometry. This guide connects secondary-antibody architecture with practical interpretation of SARS-CoV-2 vaccine studies.

8527 records 1/569 page Next 12345 下5页 Last page